Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

Kourie Hampig Raphael; Ameye Lieveke; Paesmans Marianne; Bron Dominique

首页> 外文期刊>Annals of hematology >Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

【24h】

Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

机译：回复：CALR vs. JAK2V617F突变对原发性纤维化患者脾肿大，白血病转化，血栓形成和总体生存的预后价值：一项荟萃分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of hematology》 |2016年第12期|共2页
作者
Kourie Hampig Raphael; Ameye Lieveke; Paesmans Marianne; Bron Dominique;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献

1. Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis [J] . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Annals of hematology . 2016,第12期

机译：回复：CALR vs. JAK2V617F突变对原发性纤维化患者脾肿大，白血病转化，血栓形成和总体生存的预后价值：一项荟萃分析
2. IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F [J] . A Tefferi, T Jimma, N H Sulai, Leukemia . 2012,第3期

机译：原发性骨髓纤维化中的IDH突变可预测白血病转化和缩短生存期：与JAK2V617F发生白血病的合作的临床证据
3. Mutational Profiling of JAK2V617F vs. CALR mutated Primary Myelofibrosis [J] . Santos Fabio, Puga Renato, Lisboa Bianca, Clinical lymphoma, myeloma & leukemia . 2015,第Suppla1期

机译：JAK2V617F的突变分析与Calr突变的原发性髓纤维化
4. IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F [O] . A Tefferi, T Jimma, N H Sulai, -1

机译：原发性骨髓纤维化中的IDH突变可预测白血病转化并缩短生存期：与JAK2V617F发生白血病的合作的临床证据
5. IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F [O] . Tefferi, A, Jimma, T, Sulai, N H, 2011

机译：原发性骨髓纤维化中的IDH突变预示着白血病的转化和生存期的缩短：与JAK2V617F致白血病合作的临床证据

Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

著录项

相似文献

相关主题

期刊订阅